Genea Group Media Releases April 2020

April 2020

COVID-19: Update IVF resumes

Posted: 21/04/2020 4:58:19 PM

At 1.30pm today after a National Review of COVID-19 infection rates, Prime Minister, Scott Morrison announced that restrictions will be lifted on some non-essential surgeries and that fertility clinics can return to operation. Genea is thrilled that patients can once again access our world leading fertility services.

COVID-19 Update

Posted: 1/04/2020 5:10:26 PM

On the 25th of March, the Australian Government directed that all non-essential surgeries must cease on the 1st of April 2020. Genea Medical Director, Mark Bowman discusses the impact this has on patients seeking fertility treatment.

Media Contact

Meline Walton
Media & Communications Manager
M: +61 452 433 369
E: meline.walton@genea.com.au

About Genea

Genea is one of Australia’s leading providers for infertility, IVF and other assisted conception treatment with 31 years of experience in the field. The company has long been a fertility pioneer, with research and technologies developed in-house virtually doubling IVF success rates in the mid-nineties and continuing to improve outcomes today. In September 2017, Genea was listed in the Australian Financial Review’s Top 50 Most Innovative Companies List, ranking number 25.

Our response to Novel Coronavirus (COVID-19)

For all enquiries, call:
1300 361 795

Email us

PARTNERSHIPS

Genea shares patient stories to help people experiencing infertility to understand that they are not alone. Hearing about other people experiencing the same challenges is a powerful way to break the isolation and stigma that often surrounds infertility. We share these stories with the intent to inform, educate and comfort and have no intention to create unreasonable expectations of beneficial treatment. Similarly, we have no intention for our community to believe the stories told are the outcomes that would be achieved for every patient. Read more about our policy on sharing personal stories.

Home Privacy Policy Disclaimer Genea Group